| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/03/2013 | US8524677 DNA vaccine as immunoprophylaxis against Kala-azar |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524499 For isolating an enriched or purified population of motor neurons from a mixed population of human brain and/or spinal cells; for therapeutically targeting motor neurons eg myeloradiculopathy |
| 09/03/2013 | US8524446 Method for detecting adeno-associated virus |
| 09/03/2013 | US8524368 Charge-dynamic polymers and delivery of anionic compounds |
| 09/03/2013 | US8524232 Methods of treatment using taci-immunoglobulin fusion proteins |
| 09/03/2013 | US8524220 Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria |
| 09/03/2013 | US8524219 Simian subfamily B adenoviruses SAdV-28, -27, -29, -32, -33, and -35 and uses thereof |
| 09/03/2013 | US8524218 Compositions and methods for treatment of neoplastic disease |
| 09/03/2013 | CA2736921C Tumour-associated peptides that bind to mhc molecules |
| 09/03/2013 | CA2561696C Novel modified galectin 9 proteins and use thereof |
| 09/03/2013 | CA2504963C Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer |
| 09/03/2013 | CA2464372C Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 09/03/2013 | CA2459807C Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 09/03/2013 | CA2428798C Fen-1 endonucleases from archaeoglobus veneficus |
| 09/03/2013 | CA2412581C Transforming growth factor beta (tgf-.beta.) blocking agent-treated stem cell composition and method |
| 09/03/2013 | CA2377515C Cytoplasmic transfer to de-differentiate recipient cells |
| 08/29/2013 | WO2013126794A1 Compositions and methods for the treatment of hemoglobinopathies |
| 08/29/2013 | WO2013126712A1 Compositions and methods for generating a persisting population of t cells useful for the treatment of cancer |
| 08/29/2013 | WO2013126605A1 EXPRESSION CONSTRUCT FOR A LIN28-RESISTANT Let-7 PRECURSOR MICRORNA |
| 08/29/2013 | WO2013126565A1 Downregulation of sine/alu retrotransposon transcription to induce or restore proliferative capacity and/or pluripotency to a stem cell |
| 08/29/2013 | WO2013126564A1 Conjugates, particles, compositions, and related methods |
| 08/29/2013 | WO2013064844A3 Method for de-differentiating a cell |
| 08/29/2013 | US20130225666 Delivery of polynucleotides using recombinant aav9 |
| 08/29/2013 | US20130224858 Adipose-derived stem cells and lattices |
| 08/29/2013 | US20130224313 Cancer therapy method |
| 08/29/2013 | US20130224281 Method and composition for ameliorating the effects for a subject exposed to radiation or other sources of oxidative stress |
| 08/29/2013 | US20130224261 Environmentally-responsive nanocomposites and methods of their use |
| 08/29/2013 | US20130224243 Use of herpes vectors for tumor therapy |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | US20130224163 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
| 08/28/2013 | EP2631291A2 Nucleic acid molecules inducing rna interference, and uses thereof |
| 08/28/2013 | EP2630241A2 Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua |
| 08/28/2013 | EP2629803A2 Methods and compositions for treating tumors using myeloid derived suppressor cells |
| 08/28/2013 | EP2629802A2 Novel low molecular weight cationic lipids for oligonucleotide delivery |
| 08/28/2013 | CN103270046A Methods and compositions for treating hemophilia B |
| 08/28/2013 | CN103269716A Lyophilized viral formulations |
| 08/28/2013 | CN103269708A Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain |
| 08/28/2013 | CN103266121A Replicon DNA (deoxyribonucleic acid) vaccine vector, and construction method and application thereof |
| 08/28/2013 | CN103266119A Three-antigen fusion gene vaccine of mycobacterium tuberculosis as well as preparation method and application of three-antigen fusion gene vaccine |
| 08/28/2013 | CN103266111A Dual-target siRNA (small interfering ribonucleic acid) molecule and application thereof |
| 08/28/2013 | CN103265627A HPV16L1-g protein and coding gene and application thereof |
| 08/28/2013 | CN103265625A HPV16L1-h protein and coding gene and application thereof |
| 08/28/2013 | CN103263677A MicroRNA molecule and application thereof in preparation of cancer drug |
| 08/28/2013 | CN103263676A Method for reversing drug resistance of breast cancer by using miR-487a |
| 08/28/2013 | CN102703507B shRNA lentiviral expression vector for specifically inhibiting hepatic cell CYP2E1 gene expression, constructing method and application thereof |
| 08/28/2013 | CN102580117B Application of miRNA-122 restraining agent to preparation of medicament for treating congenital heart disease |
| 08/28/2013 | CN102140473B Anti-tumor nucleic acid and polypeptide and application thereof |
| 08/27/2013 | US8519118 RIP140 regulation of glucose transport |
| 08/27/2013 | US8519111 Nucleic acid and amino acid sequences encoding high-level expressor factor VIII polypeptides and methods of use |
| 08/27/2013 | US8519109 Tumour rejection antigens |
| 08/27/2013 | US8518907 RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) |
| 08/27/2013 | US8518904 Modulation of STAT 6 expression |
| 08/27/2013 | US8518884 Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor |
| 08/27/2013 | US8518699 Methods for genetic diversification in gene conversion active cells |
| 08/27/2013 | US8518698 Method of promoting apoptosis of glioblastoma tumor cells |
| 08/27/2013 | US8518695 Compositions comprising polynucleotides encoding RDCVF1 or RDCVF2 |
| 08/27/2013 | US8518694 Nucleic acid vector comprising a promoter and a sequence encoding a polypeptide from the endogenous retrovirus PCAV |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518409 System for selective cell treatment using ideotypically modulated pharmacoeffectors |
| 08/27/2013 | US8518392 Promoter-regulated differentiation-dependent self-deleting cassette |
| 08/27/2013 | US8518391 Monocytes as a gene delivery vector for secreted proteins to treat Alzheimer'S disease |
| 08/27/2013 | CA2558371C Methods of modulating immune responses by modulating tim-1 and tim-4 function |
| 08/27/2013 | CA2526212C Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents |
| 08/27/2013 | CA2486918C Novel chimeric cd154 |
| 08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
| 08/22/2013 | WO2013123451A1 Lna antisense oligonucleotides for the modulation of myc expression |
| 08/22/2013 | WO2013123432A2 Histidyl-trna synthetases for treating autoimmune and inflammatory diseases |
| 08/22/2013 | WO2013123094A2 Systemic delivery and regulated expression of paracrine genes for cardiovascular diseases and other conditions |
| 08/22/2013 | WO2013123088A1 Agents and method for treating inflammation-related conditions and diseases |
| 08/22/2013 | WO2013121194A1 Materials and methods relating to packaging cell lines |
| 08/22/2013 | WO2013120959A1 Angiostatin chimeras and uses thereof |
| 08/22/2013 | WO2013090523A3 Methods, systems, and compositions for cell-derived/vesicle-based microrna delivery |
| 08/22/2013 | US20130217949 Combinatorial methods and compositions for treatment of melanoma |
| 08/22/2013 | US20130217118 Adipose-derived stem cells and lattices |
| 08/22/2013 | US20130217095 Chimeric adenoviruses for use in cancer treatment |
| 08/22/2013 | US20130216563 Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses Thereof |
| 08/22/2013 | US20130216500 Method of treating or retarding the development of blindness |
| 08/22/2013 | CA2850380A1 Agents and method for treating inflammation-related conditions and diseases |
| 08/21/2013 | EP2628802A1 Dna vaccine based on b7-1-pe40kdel exotoxin fusion gene and use thereof |
| 08/21/2013 | EP2628798A1 Prophylactic or therapeutic agent for fibrosis |
| 08/21/2013 | EP2628748A1 Angiostatin chimeras and uses thereof |
| 08/21/2013 | EP2627770A2 Compositions and methods for treating endocrine, gastrointestinal or autoimmune disorders |
| 08/21/2013 | EP2627766A2 Methods and compositions for the treatment of insulin-associated medical conditions |
| 08/21/2013 | EP2627665A1 Methods and compositions for treating hemophilia b |
| 08/21/2013 | EP2627359A1 Expression vector for cholesterol 24 -hydrolase in therapy of huntington' s disease |
| 08/21/2013 | EP2627339A1 A modified human u1snrna molecule, a gene encoding for the modified human u1snrna molecule, an expression vector including the gene, and the use thereof in gene therapy |
| 08/21/2013 | CN1968717B Gene delivery system containing relaxin gene and pharmaceutical composition using relaxin |
| 08/21/2013 | CN103260650A Methods and compositions for treating tumors by using myeloid derived suppressor cells |
| 08/21/2013 | CN103260649A Long lasting drug formulations |
| 08/21/2013 | CN103255206A Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 08/21/2013 | CN103255175A Magnetic nanometer gene vector system as well as preparation method and application thereof |
| 08/21/2013 | CN103255174A Ternary complex with polyethylene glycol grafted hyaluronic acid as outer layer, ternary complex liquid and application of ternary complex |
| 08/21/2013 | CN103255173A Double-promoter and double-expression specific shRNA (Short Hairpin Ribonucleic Acid) lentiviral vector and application thereof |
| 08/21/2013 | CN103255172A Inducible shRNA (short hairpin ribonucleic acid) lentiviral expression vector and construction method and application thereof |
| 08/21/2013 | CN103255171A Recombinant?virus-like particles of porcine circovirus 2 type codon optimized OFRF2 gene |
| 08/21/2013 | CN103255170A Oncolytic adenovirus construction method for targeted CD47 positive leukemia cells and application thereof |
| 08/21/2013 | CN103255169A Replication-defective arenavirus vectors |
| 08/21/2013 | CN103255137A Method for detecting SKA1 gene expression and purpose of siRNA thereof |
| 08/21/2013 | CN103255115A Penetrating TAT-TALEN protein, and preparation method and application of cell with knocked endogenous gene |